Drug Topics
MARCH 31, 2025
Jean-Venable Goode, BSPharm, PharmD, and Jeff Goad, PharmD, MPH, presented on the most notable vaccine updates from the past year and how they impact pharmacy practice.
STAT
MARCH 31, 2025
Heart disease has long been the leading killer of adults, but beyond that stark fact, men and women diverge. From differences at the cellular level of the heart to circulatory structure to symptoms of distress and treatment, researchers are finding new manifestations of gender differences in cardiovascular disease.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 31, 2025
Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.
STAT
MARCH 31, 2025
Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the local hospital. She’s already arranged child care for her son, but cancellations are common. “It’s a gamble. … I’ll wake up at 5 in the morning, and I’ll find out if I’m canceled or not,” she told us.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 31, 2025
Lydia Newsom, PharmD, discusses injection techniques, managing side effects, and the importance of collaboration between the healthcare team.
STAT
MARCH 31, 2025
The forced resignation of Peter Marks , the Food and Drug Administration official in charge of regulating vaccines, gene therapies, and the blood supply, led to panic over the weekend in the worlds of public health and biopharmaceuticals — two worlds that often agree on very little aside from their belief in the safety and effectiveness of vaccines.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 31, 2025
I will never forget stepping into the cadaver lab for the first time. As the doors swung open, a sharp, sour wave of formaldehyde hit me and made my stomach churn. I pulled my thin polyester scrub shirt over my nose, but it did little to block the smell, let alone shield me from the bone-chilling temperature. Steel tables surrounded me, each holding a body, and I could see grayish-yellow skin peeking out from beneath the white drapes.
Drug Topics
MARCH 31, 2025
As information changed rapidly, pharmacists quickly adapted their strategies by leveraging social media for updates to patients.
STAT
MARCH 31, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Happy Monday — it’s Sarah subbing in. A colleague at one of my old jobs used to love using the icebreaker, “Would you rather be a dog or a ghost?” (H/T GQ.) Maybe try it at your next networking event and report back on how it goes?
Drug Topics
MARCH 31, 2025
Investigators said that targeted education and interventions are key to the long term success of community pharmacy immunization programs.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
MARCH 31, 2025
The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.
Pharmacy Times
MARCH 31, 2025
A phase 1/2 clinical trial will provide crucial data on the vaccine's tolerability and pave the way for future development and potential widespread use.
STAT
MARCH 31, 2025
This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday. Sign up here. Boy, last week was a doozy. More government layoffs, a national security leak, and everyone’s mad about The Bachelor’s pick. Let’s catch you up. As always, please direct your tips to tara.bannow@statnews.com.
Hospital Pharmacy Europe
MARCH 31, 2025
Sustainability has become central to the mission of hospital pharmacists, who are uniquely positioned to minimise waste, reduce healthcares environmental footprint and enhance patient outcomes. In his latest commentary, Dr Joo Gonalves PhD explores how digital health tools, artificial intelligence and circular economy models can drive meaningful change in hospital pharmacy practice.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmafile
MARCH 31, 2025
The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat haemophilia A or B, with or without inhibitors. The approval of the antithrombin-lowering (AT) drug was based on data from the ATLAS phase 3 studies that Sanofi conducted. Sanofi is an international pharma and healthcare […] The post Qfitlia approved by FDA to treat haemophilia A or B appeared first on Pharmafile.
The Checkup by Singlecare
MARCH 31, 2025
With the skyrocketing popularity of injectable medications Ozempic and Wegovy , a shortage inevitably followed. Ozempic and Wegovy (and Rybelsus , which is oral semaglutide) are GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s) and are the only FDA-approved drugs that contain the active ingredient semaglutide.
Fierce Healthcare
MARCH 31, 2025
Oracle Health, which has not publicly reported the incident, reportedly told customers on Feb. 20 that its legacy Cerner systems were breached sometime after Jan. 22.
Pharma Marketing Network
MARCH 31, 2025
Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. As industry leaders adapt to digital-first communication and omnichannel engagement, the need for smart, scalable, and strategic marketing tactics is more urgent than ever. Whether you’re launching a new branded drug or optimizing an established portfolio, staying ahead of the curve in pharmaceutical marketing has be
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
MARCH 31, 2025
Ozempic is the brand name for semaglutide, which is a medication thats FDA approved to treat high blood sugar in people with Type 2 diabetes. It is also often prescribed off-label as a weight loss medication, even in patients with normal blood sugars. Ozempic is a type of medication called a glucagon-like peptide-1 agonist (GLP-1) and is only given by injection.
PharmaVoice
MARCH 31, 2025
This technology brings both benefits and drawbacks for the field, which is also testing alternatives.
Pharmafile
MARCH 31, 2025
ProBioGen has announced the appointment of Alfred Merz as its chief executive officer (CEO), effective 1 April 2025. Merz, who was previously chief operating officer (COO) and interim CEO, now assumes leadership of the company. Merz has over 30 years’ worth of experience in manufacturing, operations and strategy development. Before joining ProBioGen 2024, he was […] The post Alfred Merz appointed as CEO of ProBioGen appeared first on Pharmafile.
PharmaVoice
MARCH 31, 2025
From accelerating drug discovery to improving disease detection, AI is transforming the way we understand and manage health.
pharmaphorum
MARCH 31, 2025
The CHMP has advised against EU approval of Eli Lilly's Alzheimer's drug Kisunla, potentially handing an advantage to Eisai/Biogen's rival drug
Pharmacy Times
MARCH 31, 2025
Currently, BEAM-302 is undergoing a phase 1/2 clinical trial to evaluate its efficacy in patients with alpha-1 antitrypsin deficiency (AATD) who have lung disease and liver disease.
Pharmaceutical Technology
MARCH 31, 2025
The funding is set to accelerate the development of Isomorphics AI drug design engine and advance clinical programmes.
pharmaphorum
MARCH 31, 2025
Novo Nordisk's Ozempic has been shown to improve walking distance in people with diabetes and peripheral artery disease in the STRIDE trial
Pharmacy Times
MARCH 31, 2025
Marc Humbert, MD, PhD, shared data that were presented at the ACC 2025 Scientific Sessions.
pharmaphorum
MARCH 31, 2025
Industry organisations are alarmed by the resignation of senior FDA official Peter Marks, citing "misinformation and lies" by HHS Secretary Kennedy
Pharmacy Times
MARCH 31, 2025
Anna Sophie Mueller, MD discusses how imaging could advance risk identification in cardiovascular care.
pharmaphorum
MARCH 31, 2025
Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine and advance its pipeline.
Pharmacy Times
MARCH 31, 2025
Effective management of immune checkpoint inhibitor-related toxicities requires early intervention, evolving guideline adherence, and multidisciplinary collaboration, with steroids remaining a key treatment.
STAT
MARCH 31, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we process the shockwaves in biotech following the ouster of CBER chief Peter Marks, see a radiopharmaceutical expand its reach, and more.
Pharmacy Times
MARCH 31, 2025
Pharmacists play a key role in COVID-19 management by educating patients on treatment, monitoring drug interactions, promoting vaccination, and addressing hesitancy.
Expert insights. Personalized for you.
503 
Let's personalize your content